DOH Considers a Japanese Anti-Flu Drug as Treatment for COVID-19 Patients

The Philippines’ Department of Health is currently looking into bringing a Japanese anti-flu medication into the country after it was found to be a “very promising” treatment for coronavirus disease 2019 (COVID-19).

medical treatment hospital medicine e1510731774236

(WHO’s COVID-19 Treatment Trial Has Found Its First Patients)

Very promising po siya, mukha po talaga siyang sa ngayon sa mga anti-viral ay ito po ang parang medyo directed po ang treatment towards talagang [sa] COVID-19,” Health Undersecretary Eric Domingo said in an interview over Dobol B at News TV.

[It’s very promising, it seems to be anti-viral so it would be directed towards COVID-19.]

“Of course… this is a very early development drug, at nakita po na meron siyang positive response sa mga pasyente sa kanya [it was seen to have a positive response on patients],” he added.

However, as the director-general of the Food and Drug Administration, Domingo noted that the drug Avigan is not actually being distributed in the Philippines yet. It is also not yet being produced in commercial quantity.

Kasi nga dinedevelop pa, wala pa po siyang production in commercial quantity pero tinitingnan din po natin kung pano siya maipapasok sa Pilipinas,” he said.

What do you think about this?

Do you have a story for the WhenInManila.com Team? Email us at story.wheninmanila@gmail.com or send us a direct message at WhenInManila.com Facebook Page. Interact with the team and join the WhenInManila.com Community at WIM Squad!